Antiviral drugs have traditionally been developed by directly targeting essential viral
components. However, this strategy often fails due to the rapid generation of drug-resistant …

Remdesivir (RDV), a broadly acting nucleoside analogue, is the only FDA approved small
molecule antiviral for the treatment of COVID-19 patients. To date, there are no reports …

The odds of living a long and healthy life with HIV infection have dramatically improved with
the advent of combination antiretroviral therapy. Along with the early development and …

The consumption of plant sprouts as part of human day-to-day diets is gradually increasing,
and their health benefit is attracting interest across multiple disciplines. The purpose of this …

Favipiravir is a nucleoside analogue that inhibits the replication and transcription of a broad
spectrum of RNA viruses, including pathogenic arenaviruses. In this study, we isolated a …

The variety of available biocidal features make nanomaterials promising for fighting
infections. To effectively battle COVID-19, categorized as a pandemic by the World Health …

Delay in viral production may have a significant impact on the early stages of infection.
During the eclipse phase, the time from viral entry until active production of viral particles, no …

Malaria infection is often accompanied by periodic fevers, triggered by synchronous cycles
of parasite replication within the host. The degree of synchrony in parasite development …

The Amazonian species investigated in this research are commonly utilized for their anti-
inflammatory properties and their potential against various diseases. However, there is a …

Abstract Mycobacterium Tuberculosis (Mtb) causing Tuberculosis (TB) is a widespread
disease infecting millions of people worldwide. Additionally, emergence of drug resistant …